The Medicines and Healthcare products Regulatory Agency (MHRA) assesses its regulatory impact on businesses.
The business impact target (BIT) is a cross-government target for the reduction of regulation on business.
Under the BIT, MHRA assesses the financial impacts on business of qualifying regulatory provisions (QRPs). QRPs are changes to regulatory practices that are described in a written ministerial statement. We assess the impacts of these changes through BIT assessments.
We submit BIT assessments for QRPs to the Regulatory Policy Committee (RPC) for validation.
Non-qualifying regulatory provisions (NQRPs) are excluded from the BIT as set out in a written ministerial statement. We submit NQRP summaries to the RPC for certification.